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ABSTRACT: For applications where degradable polymers are
likely to have extended blood contact, it is often important for
these materials to exhibit high levels of thromboresistance.
This can be achieved with surface modiﬁcation approaches, but
such modiﬁcations may be transient with degradation.
Alternatively, polymer design can be altered such that the
bulk polymer is thromboresistant and this is maintained with
degradation. Toward this end a series of biodegradable, elastic
polyurethanes (PESBUUs) containing diﬀerent zwitterionic
sulfobetaine (SB) content were synthesized from a polycaprolactone-diol (PCL-diol):SB-diol mixture (100:0, 75:25, 50:50, 25:75
and 0:100) reacted with diisocyanatobutane and chain extended with putrescine. The chemical structure, tensile mechanical
properties, thermal properties, hydrophilicity, biodegradability, ﬁbrinogen adsorption and thrombogenicity of the resulting
polymers was characterized. With increased SB content some weakening in tensile properties occurred in wet conditions and
enzymatic degradation also decreased. However, at higher zwitterionic molar ratios (50% and 75%) wet tensile strength exceeded
15 MPa and breaking strain was >500%. Markedly reduced thrombotic deposition was observed both before and after substantial
degradation for both of these PESBUUs and they could be processed by electrospinning into a vascular conduit format with
appropriate compliance properties. The mechanical and degradation properties as well as the acute in vitro thrombogenicity
assessment suggest that these tunable polyurethanes could provide options appropriate for use in blood contacting applications
where a degradable, elastomeric component with enduring thromboresistance is desired.
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■ INTRODUCTION
A variety of approaches have been pursued to reduce the
thrombogenicity of polymers intended for device applications
with extended blood contact, including high hydrophobicity,1
high hydrophilicity,2 heparinization,3,4 zwitterion incorpora-
tion,5,6 and biomimetic design strategies.7,8 Incorporating
zwitterionic groups, such as phosphorylcholine (PC), sulfobe-
taine (SB) or carboxybetaine (CB) on blood contacting
surfaces has been shown in a number of systems to be an
eﬀective and convenient approach to minimize protein
adsorption and platelet deposition.6,9−11 SB-containing mono-
mers are relatively cheap and easily obtained compared to the
PC and CB, whereas surfaces modiﬁed with SB-containing
molecules have exhibited antifouling and antithrombogenic
properties similar to surfaces modiﬁed with other zwitterionic
groups.12−14 SB has often been used in strategies to reduce
surface fouling on nondegradable biomaterials,15,16 whereas
only recently has this zwitterion been considered for
incorporation in blood contacting biodegradable polymers.17,18
Biodegradable polyurethane materials have been evaluated
for potential use in several cardiovascular applications,
including as scaﬀolds for tissue engineered vascular grafts and
stent coatings.19−21 Surface modiﬁcation,15,22 functional moiety
incorporation,18,23 and controlled release of bioactive agents24
have been employed to improve polyurethane blood compat-
ibility. For biodegradable polyurethane vascular scaﬀolds, PC
surface modiﬁcation and PC copolymer blending have
exhibited good thromboresistance in vitro and in vivo.25,26 In
another approach, designed to modify the polyurethane
backbone throughout the bulk phase of the polymer, PC
moieties were conjugated as pendant groups onto poly(ester
urethane) ureas containing pendant COOH groups (PEUU−
PC).27,26 However, PEUU−PC polymers had a limited capacity
for PC grafting due to limits on the extent of COOH group
incorporation with the synthetic scheme employed.
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In this study, biodegradable, elastic polyurethanes with SB
incorporated into the polymer backbone were synthesized,
where SB content in the polymer could be readily tuned by
altering the molar ratio of diols employed in the synthesis.
Speciﬁcally, SB with two hydroxyl end groups (SB-diol) was
synthesized followed by blending of SB-diol and polycapro-
lactone-diol at diﬀerent molar ratios prior to reaction with
diisocyanatobutane followed by chain extension with putres-
cine. This approach is straightforward and does not require a
subsequent step to graft on the biofunctional moieties. The
chemical structure, mechanical properties, thermal properties,
hydrophilicity, biodegradability, and thrombogenicity of the
resulting polymers was characterized. Surface protein deposi-
tion was evaluated using ﬁbrinogen as a model protein. Whole
ovine blood was used to assess platelet deposition on the
developed polyurethanes before and after degradation for
maintenance of thromboresistance. One of the promising
polymers was processed by electrospinning into a conduit that
would be structurally appropriate for use as a vascular graft.
■ EXPERIMENTAL SECTION
Materials. N-Butyldiethanolamine and 1,3-propane sultone were
purchased from Sigma-Aldrich and used without further puriﬁcation.
Polycaprolactone diol (number-average molecular weight 2000, PCL-
diol, Sigma) was dried in vacuum oven at 60 °C prior to synthesis.
Putrescine (Sigma) and diisocyanatobutane (BDI, Sigma) were
puriﬁed by a vacuum distillation. Stannous octotate (Sn(Oct)2) was
dried using 4 Å molecular sieves (Sigma). Dimethyl sulfoxide (DMSO,
anhydrous ≥99.9%, Sigma), 1,1,1,3,3,3-hexaﬂuoroisopropanol (HFIP,
Oakwood Inc.), and other chemicals used as received, except what
mentioned above.
Synthesis of Sulfobetaine-diol. Sulfobetaine with two hydroxyl
groups (SB-diol) was synthesized from 1,3-propane sultone (PS) and
N-butyldiethanolamine (BDEA) (Figure 1A). Brieﬂy, 0.3 M PS and
BDEA were dissolved together in 200 mL of anhydrous methylene
chloride in a round-bottom ﬂask with a stir bar. After argon injection
for 20 min, the ﬂask was sealed and the mixture stirred for 15 h at 40
°C. The solvent was then removed from the reaction mixture using a
rotary evaporator and a white precipitate was obtained. The product
was washed several times with diethyl ether to remove unreacted
species. The chemical structure was conﬁrmed by proton nuclear
magnetic resonance (1H NMR, BrukerBiospin Co., Billerica, MA). For
SB-diol (in D2O), the peaks were: δ (ppm) 0.85−0.95 (CH2CH3),
1.30−1.40 (CH2CH2CH2), 1.65−1.75 (CH2CH3), 2.10−2.20
(CH2CH2SO3), 2.90−3.00 (CH2SO3), 3.40−3.60 ((CH2)4N),
3.95−4.05 (CH2OH)2 (see the Supporting Information, Figure S1).
Synthesis and Processing of Polyurethane Ureas Containing
Sulfobetaine (PESBUUs). PESBUUs were synthesized using a two-
step solvent polymerization in a manner similar to that previously
reported28 with the synthesis scheme shown in Figure 1B. PCL-diol
and SB-diol were blended at diﬀerent molar ratios, respectively: 100:0,
75:25, 50:50, 25:75, and 0:100 (designated PESBUU-0, PESBUU-25,
PESBUU-50, PESBUU-75, and PESBUU-100), and then were
dissolved in DMSO at 70 °C in a three-necked ﬂask with argon
protection and agitation. BDI was added into the ﬂask, following three
droplets of catalyst Sn(Oct)2. The reaction was carried out for 3 h at
70 °C, followed by cooling down the prepolymer solution to room
temperature, and then adding a putrescine/DMSO solution dropwise
into the ﬂask. The reaction continued overnight, and then the polymer
was precipitated in diethyl ether and dried in a vacuum oven at 60 °C
for 3 days. The (PCL-diol+SB-diol):BDI:putrescine molar ratio was
Figure 1. Schematic synthesis of (A) sulfobetaine-diol (SB-diol) and (B) biodegradable polyester sulfobetaine urethane ureas (PESBUUs).
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set at 1:2:1. Polymer yields were above 80%. Polymer ﬁlms were
fabricated by solvent casting using HFIP, followed by drying in a
vacuum oven at 60 °C for 3 days.
Eletrospun ﬁbrous sheets and conduits were fabricated from
PESBUUs using methods previously described.25 Brieﬂy, the PESBUU
was dissolved in HFIP (8 wt %) and the solution was fed at 1 mL/h by
syringe pump (Harvard Apparatus, U.S.) into a steel capillary (ID =
1.2 mm) that was suspended 14 cm over a stainless steel mandrel (19
mm diameter for a sheet and 1.0 or 1.6 mm diameter for a conduit).
The mandrel was rotated at 250 rpm and rastered upon an x−y stage
(Velmex, U.S.) which was reciprocally translated in the direction of the
mandrel axis at a speed of 6 cm/s with an amplitude of 8 cm. Two
high-voltage generators (Gamma High Voltage Research, U.S.) were
used to charge the polymer feeding capillary to 7 kV and the mandrel
to −10 kV. The electrospun sheets and conduits were removed from
the mandrels after electrospinning for 4 h for a sheet or 15 min for a
conduit.
Polymer Characterization. 1H NMR with DMSO-d6 solvent was
used to verify polymer chemical structure. Glass transition temper-
atures (Tg) and melting temperatures (Tm) were detected on a
Shimazu diﬀerential scanning calorimetry (DSC, DSC-60, Shimazu) at
a scanning range of −100 to 200 °C with a heating rate of 20 °C/min
and a nitrogen ﬂow. Intrinsic viscosity of the synthesized polymers was
measured using an Ubbelohde viscometer at 22 °C.28 Each polymer
was dissolved in 20 mL of HFIP at a concentration of 0.6 g/dL and
then ﬁltered using an 0.45 μm polytetraﬂuoroethylene ﬁlter. The eﬄux
time of each polymer sample and HFIP was measured to calculate the
intrinsic viscosity as ln(tp/ts)/Cp, where tp represents the polymer
solution eﬄux time, ts represents the HFIP eﬄux time, and Cp is the
polymer concentration. Water absorption of polymer ﬁlms was
measured by immersing a weighted ﬁlm (W0) in Dulbecco’s phosphate
buﬀered saline (DPBS, without calcium or magnesium) at 37 °C for
24 h and then weighting the wetted sample (W1). The water
adsorption was calculated as (W1−W0)/W0 × 100%.
Mechanical Testing. Mechanical properties of cast ﬁlms were
measured using an MTS Tytron 250 MicroForce Testing Workstation
at room temperature with a crosshead speed of 25 mm/min. Five
dumbbell-shaped strips (2 × 18 mm) were cut from PESBUU-0,
PESBUU-25, PESBUU-50, PESBUU-75 and PESBUU-100 polymer
ﬁlms and tested. The mechanical properties of polymers in wet
conditions were measured after the dumbbell-shaped strips of
PESBUUs ﬁlms were immersed in DPBS at 37 °C for 24 h. Cyclic
tensile testing29 was conducted using a uniaxial cyclic tensile testing
system (model PCI-MIO-16XE-10, National Instruments) to evaluate
the elastic properties of the PESBUU polymers by stretching to
maximum strains of 30% or 400% and retracing back to the initial
length for 10 cycles at a rate of 150 mm/min.
The mechanical properties of electrospun ﬁbrous sheets were also
measured with a crosshead speed of 10 mm/min on dumbbell-shaped
strips of PESBUUs under wet conditions. For compliance testing of
electrospun conduits, 1 mm diameter vessel segments, 18 mm in
length were obtained from each PESBUU conduit with 3 samples/
group tested. The test circuit (see the Supporting Information, Figure
S2A) was assembled using polyvinyl chloride tubing, connectors and
stopcocks (Value Plastics, Inc.). Surgical suture (Henry Schein) was
used to secure each segment to a Precision Guide needle (Becton
Dickenson) ∼2 mm in diameter. Samples were fully submerged in
water at room temperature (see the Supporting Information, Figure
S2B). Hydrostatic pressure (10, 20, 30, 60, and 100 mmHg) was
generated using a 10 L tank ﬁlled with water and placed at diﬀerent
heights. A programmable PHD 2000 Harvard Apparatus syringe pump
with a 60 mL syringe was used to generate a constant ﬂow (10 mL/
min) in the circuit. Ten images of the entire vessel were captured at
each pressure value using a Canon EF 50 mm f/2.5 Compact Macro
Lens. The pressure signal was acquired with a SPR-320 Mikro-Tip
pressure catheter (Millar) equipped with a PCU-2000 pressure control
unit (Millar) and recorded with LabVIEW. Data postprocessing was
performed by a custom-made script developed in Matlab where vessel
diameters were calculated by digital image analysis and related to the
correspondent pressure value. Global compliance25 was calculated
using
= −
−
C
P P
(OD OD )/OD90 60 60
90 60 (1)
where OD and P are the vessel outer diameter and pressure,
respectively.
Polymer Degradation. Polymer ﬁlms (150 ± 50 μm thickness, n
= 4) of each type were weighed (W0) and then placed in 10 mL of
DPBS or 100 U lipase/DPBS mixed solution at 37 °C for hydrolytic or
enzymatic degradation measurements, respectively. At each time point,
the sample was washed using deionized water, dried in a vacuum oven
at 60 °C for 3 days, and then weighed (W1). For the enzymatic
degradation measurement, the fresh lipase/DPBS solution was
exchanged every 3 days. At predetermined time points, the sample
was rinsed 3× using deionized water and then dried in a vacuum oven
at 60 °C for 3 days followed by weighing (W1). The mass remaining
was calculated as W1/W0 × 100%.
Figure 2. 1H NMR spectra of PESBUU-0, PESBUU-50, and PESBUU-100. Peaks attributable to SB are designated with blue arrows and peaks
attributable to PCL with red arrows.
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Protein Adsorption (Ovine Fibrinogen As a Model Protein).
Surface protein adsorption on the PESBUU ﬁlms was assessed by a
microbicinchoninic acid (BCA) assay.30 Ovine ﬁbrinogen (Sigma)
solution was prepared in DPBS at a concentration 0.03 g/dL. The
samples were immersed in the ﬁbrinogen solution at 37 °C for 3 h.
The samples were washed with DPBS, and then the absorbed protein
was detached in 1 wt % aqueous solution of sodium dodecyl sulfate
solution by shaking for 3 h at room temperature to detach the
adsorbed protein on the surface.30 A protein analysis kit (Quantipro-
Micro BCA kit, Sigma-Aldrich, St. Louis, MO) based on the BCA
method was utilized to quantify adsorbed ﬁbrinogen. The mean value
of ﬁbrinogen adsorption from three independent samples, each
measured in triplicate, was determined.
Ovine Blood Contact Test (with/without degradation).
Whole ovine blood was collected by jugular venipuncture. NIH
guidelines for the care and use of laboratory animals were observed,
and all animal procedures were approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Pittsburgh. In
vitro thrombotic deposition on the polymer samples was assessed by a
simple rocking test13 with heparinized ovine blood (heparin 3.0 U/mL
added as a minimum anticoagulant for the test). Also polymer samples
exposed to the enzymatic degradation test for 2 wk and 2 mo were
evaluated to investigate changes in thrombogenicity during the
polymer degradation that might indicate a risk for late thrombosis
after material implantation. Each polymer membrane type was cut into
10 mm diameter disks, sterilized with ethanol and placed in a test tube
(BD Vacutainer, with no additives). The test tube was ﬁlled with 4 mL
of ovine blood and gently rocked for 2 h at 37 °C on a hematology
mixer (Fisher Scientiﬁc, Pittsburgh, PA). After ovine blood contact,
the polymer membrane surfaces were rinsed with DPBS (10 times) to
remove any nonadherent blood contents. Samples were then
immersed in a 2.5% glutaraldehyde solution of DPBS for 2 h at 4
°C to ﬁx the surface adherent platelets and then serially dehydrated
with solutions of increasing ethanol content. Each sample surface was
observed by scanning electron microscopy (SEM; JSM-6330F, JEOL
USA, Inc., Peabody, MA) after sputter coating with gold/palladium.
Deposited platelets on each surface were quantiﬁed by a lactate
dehydrogenase (LDH) assay13 with an LDH Cytotoxicity Detection
Kit (Clontech Laboratories, Inc. Mountain View, CA). Four samples
for each group were performed.
Statistical Analyses. The results are presented as mean ±
standard deviation (SD). Data were analyzed by one-way ANOVA
followed by a post hoc Neuman-Keuls testing. Signiﬁcant diﬀerences
were considered to exist at p < 0.05.
■ RESULTS
Polymer Characterization. Typical 1H NMR spectra of
PESBUU-0, PESBUU-50 and PESBUU-100 are shown in
Figure 2. PESBUU-0 synthesized using only PCL-diol shows
typical peaks at 1.3−1.5 ppm (CH2), 2.25 ppm (OCCH2) and
3.95 ppm (COCH2) originating from the PCL (red arrows).
PESBUU-50 has the same peaks of the PCL as well as three
new peaks at 0.85 ppm (CH2CH3), 2.05 ppm (CH2CH2SO3),
2.90 ppm (CH2SO3), 3.55 ppm (NCH2) and 4.35 ppm
(CH2O) from the SB (blue arrows). The peaks from SB were
more apparent in PESBUU-100 which was synthesized with
SB-diol only, whereas the peaks from PCL disappeared.
Figure 3. Diﬀerential scanning calorimetry spectra of PESBUUs.
Table 1. Thermal and Mechanical Properties of PESBUUsa
tensile strength (MPa) strain at breaking (%) initial modulus (MPa)
sample Tg (
oC)
Tm
(oC)
Xc
(%)b dry wet dry wet dry wet
inherent viscosity
(dL/g)
PESBUU-0 −58 32 32 37 ± 3d 39 ± 5d,e 1001 ± 92f 1017 ± 112e 26 ± 2c 22 ± 3d 1.24
PESBUU-25 −58 26 23 43 ± 7d,e 41 ± 5e 825 ± 68e 873 ± 54d 22 ± 5c 16 ± 2c 1.23
PESBUU-50 −58 40 34 48 ± 7e 33 ± 4d,g 851 ± 78e 749 ± 50d,g 24 ± 4c 15 ± 2c,g 1.08
PESBUU-75 −66 19 10 42 ± 6d,e 15 ± 1c,g 629 ± 47d 565 ± 36c,g 90 ± 20d 16 ± 3c,g 0.80
PESBUU-100 16, 97 21 ± 3c 85 ± 16c 265 ± 50e 0.48
aStatistical comparisons of properties were made between PESBUU types under dry and wet conditions, respectively. bCrystallinity (Xc) % = 100 ×
ΔH/ΔH100%, where ΔH100% is the heat fusion of a perfect crystal of PCL, which was taken as 136 J/g.47,48 c, d, e, and f denote statistically distinct
groups for each property and condition. g denotes a statistical diﬀerence in comparing between dry and wet conditions within a given PESBUU type.
ACS Applied Materials & Interfaces Research Article
dx.doi.org/10.1021/am506998s | ACS Appl. Mater. Interfaces XXXX, XXX, XXX−XXXD
Thermal properties are presented in Figure 3. The PESBUUs
showed melting temperatures in the 25−40° range with the
exception of PESBUU-100, which lacked PCL. The glass
transition temperature (Tg) for all polymers was lower than
−50 °C, again with the exception of PESBUU-100 where no Tm
could be clearly determined in the range of that seen for the
other polymers (Table 1) and where there were two apparent
Tgs values were seen.
Mechanical Properties. Representative stress−strain
curves for the PESBUUs in dry and wet conditions are
shown in Figure 4 and the calculated mechanical parameters are
summarized in Table 1. The mechanical properties were seen
to vary with the relative portions of SB and PCL in the
PESBUUs. Under dry conditions the PESBUU-50 had a
statistically higher maximum tensile strength compared to the
PESBUU-0 control synthesized from only PCL-diol, although
PESBUU-25 and PESBUU-75 did not show signiﬁcant
diﬀerences with PESBUU-0. The strain at break of the
PESBUUs decreased with increasing of SB content. The
PESBUU-75 exhibited a signiﬁcantly higher initial modulus
compared to PESBUU-0, PESBUU-25, and PESBUU-50,
whereas PESBUU-100 synthesized from only SB-diol was
signiﬁcantly stiﬀer than all of the other PESBUUs polymers
with the lowest strain at break (85 ± 16%).
The mechanical properties for the wet polymers showed
diﬀerences for the higher SB content polymers (Table 1).
Figure 4. Typical stress−strain curves of cast PESBUU ﬁlms measured under (A) dry and (B) wet conditions. PESBEUU-100 was too weak to assess
under wet conditions.
Figure 5. Cyclic tensile curves at (A) 30% and (B) 400% strain for PESBUUs.
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Whereas PESBUU-0 and PESBUU-25 did not exhibit
signiﬁcant diﬀerences compared to the dry state, the properties
of PESBUU-50 and PESBUU-75 were decreased. However, the
PESBUU-50 polymer still had a similar tensile strength (33 ± 4
MPa) with the PESBUU-0 and the strain at break was 749 ±
50% in the wet condition. The mechanical properties of
PESBUU-100 could not be measured because the polymer
became weak and too soft to measure in the wet condition.
Figure 5 shows the results of cyclic tensile testing with a
maximum strain of 30% (Figure 5A) and 400% (Figure 5B). All
of the PESBUU polymers exhibited large hysteresis loops in the
ﬁrst cycle, followed by much smaller hysteresis loops in the next
nine cycles. With a maximum strain of 30%, the majority of
samples showed a 5−10% unrecoverable deformation, whereas
PESBUU-100 had a slightly higher set than the others. The
hysteresis loops of the next nine cycles were increased gradually
with increasing SB content, and the PESBUU-100 showed
clearly diﬀerent behavior in this regard than the PESBUU-0. At
a maximum strain of 400%, the unrecoverable deformations
were much higher (200−250%) for all PESBUU samples
compared to that seen with 30% maximum strain, but the trend
in the hysteresis loops was similar to that observed at 30%
strain. The PESBUU-100 that could not elongate to 400%, and
thus cyclic testing at this high strain was not possible.
The mechanical properties for electrospun sheets and
conduits of PESBUU-0, PESBUU-50 and PESBUU-75 under
wet conditions are summarized in Table 2. The electrospun
sheets showed 4.8−9.5 MPa tensile strength, 163−301% strain
at break, and 2.5−4.7 MPa initial modulus. The PESBUU-50
electrospun sheets still exhibited similar mechanical properties
with PESBUU-0 control, although the PESBUU-75 showed
signiﬁcantly decreased tensile strength and strain at break.
Compliance of the PESBUU-50 conduit (1.0 mm diam)
calculated between 60 and 90 mmHg of hydrostatic pressure
was 4.0 ± 2.4 × 10−4 mm Hg−1 (Table 2).
Water Absorption and Protein Adsorption. Water
absorption for each of the PESBUUs ﬁlms is shown in Figure
6A. Water absorption gradually increased with increasing SB
content, and the wt % of absorbed water reached up to 28.1%
for PESBUU-100. In contrast, the absorption for PESBUU-0
and PESBUU-50 were 1.6 and 5.7%, respectively.
The amount of adsorbed ovine ﬁbrinogen on the PESBUU
polymer ﬁlms is summarized in Figure 6B. Fibrinogen
adsorption gradually decreased with increasing SB content in
the PESBUU polymers, although between the two relatively
high SB content and the two relatively low SB content
polymers the adsorption was statistically comparable.
Polymer Degradation. The polymer degradation behavior
in lipase solution measured for 3 months is shown in Figure 7.
The PESBUU-0 control experienced 89% weight loss in one
month. However, the amount of mass loss was reduced with
increasing SB content such that PESBUU-25 required an
additional month to reach 87% mass loss, and the PESBUU-50
showed 64% weight loss at 3 months. PESBUU-75 only lost 7%
Table 2. Mechanical Properties of Electrospun PESBUU
Sheets under Wet Conditions
sample
tensile
strength
(MPa)
strain at
breaking
(%)
initial
modulus
(MPa)
compliance (×
10−4 mm
Hg−1)a
PESBUU-0 9.5 ± 2.3c 278 ± 27c 4.7 ± 1.7b 7.2 ± 2.0b
PESBUU-50 7.9 ± 1.8c 301 ± 23c 2.5 ± 0.7b 4.0 ± 2.4b
PESBUU-75 4.8 ± 1.2b 163 ± 29b 3.5 ± 1.1b 5.3 ± 1.0b
aCompliance values were calculated between 60 and 90 mmHg. b and c
denote statistically distinct groups for each property and condition.
Figure 6. (A) Water absorption after immersion in DPBS for 24 h at 37 °C and (B) ovine ﬁbrinogen adsorption on PESBUUs ﬁlms.
Figure 7. Mass remaining for PESBUUs ﬁlms in 100 U/mL lipase
solution of PBS at 37 °C.
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mass at 3 months, and PESBUU-100 ﬁlms fractured into small
pieces during the test period, making accurate mass measure-
ments impractical, although the pieces did not appear to
obviously be losing mass. In DPBS alone, without lipase,
polymer degradation was much reduced and did not vary
between polymer types (see the Supporting Information,
Figure S3).
Ovine Platelet Deposition and Electrospun Scaﬀolds.
Platelet deposition from whole ovine blood onto PESBUU
ﬁlms observed by scanning electron microscopy after blood
contact for 2 h is shown in Figure 8A. The PESBUU-0 surfaces
showed moderate levels of platelet deposition and the
deposited platelet aggregates were observed over the blood
contacting area. Platelet deposition decreased with increasing
SB content. Deposited platelets were sparse on the PESBUU-
50 ﬁlms and ﬁnding deposited platelets on PESBUU-75 and
PESBUU-100 surfaces was diﬃcult. Quantiﬁcation of platelet
deposition using an LDH assay (Figure 8B) conﬁrmed the
visual results, with platelet deposition reduced on PESBUU-25
and further decreased on PESBUU-50, PESBUU-75 and
PESBUU-100 polymers, where the average reduction versus
PESBUU-0 reached up to 95%.
To qualitatively investigate the retention of the non-
thrombogenic character for degrading PESBUU samples,
Figure 8. Ovine blood platelet deposition on PESBUU ﬁlms (A) observed by scanning electron microscopy after contact with ovine blood (heparin
3U/mL) for 2 h at 37 °C. (B) Platelet deposition on polymer ﬁlms as quantiﬁed by LDH assay.
Figure 9. (A) Scanning micrographs and (B) confocal micrographs of partially degraded PESBUU-0 (2 wk), PESBUU-50 (2 mo), and PESBUU-75
(2 mo) after contact with ovine blood (heparin 3 U/mL) for 2 h (deposited platelets were stained with ﬂuorescent mepacrine).
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ovine blood was contacted with PESBUU samples after
enzymatic degradation testing (Figure 9). The PESBUU-0
obtained after 2 weeks (wk) showed scattered deposited
platelets and platelet aggregates (Figure 9). However, it was
hard to ﬁnd deposited or aggregated platelets on the PESBUU-
50 and PESBUU-75 polymer surfaces that had been partially
degraded over 2 months (mo). Confocal micrographs (Figure
9B) obtained after ﬂuorescently staining deposited platelets
showed that there was rare platelet deposition on the PESBUU-
50, and the PESBUU-75 also did not show any notable platelet
deposition.
PESBUU was readily processable with electrospinning, into
both sheet and small conduit formats. The latter conduits
(Figure 10A) were generated at a size compatible with large
rodent implantation. The former were used to further explore
thrombogenicity of the ﬁbrous polymer surface. Macroscopic
and electron micrographs of electrospun PESBUU sheets after
contact with ovine blood (heparin 3U/mL) for 3 h are shown
in Figure 10B, C. After the ovine blood contact, thrombotic
deposition was apparent on the PESBUU-0 electrospun sheet
at both the macroscopic and microscopic level, with the latter
exhibiting deposited platelet aggregates with some entrapped
erythrocytes. Macroscopic thrombotic deposition was visibly
decreased on the PESBUU-25 and not noted on the
electrospun scaﬀolds of PESBUU-50 and PESUU-75 (Figure
10B), which corresponded with micrographs showing sparsely
deposited platelets on PESBUU-50 and PESBUU-75 electro-
spun scaﬀolds (Figure 10C).
■ DISCUSSION
Poly(ester urethane)ureas combined with zwitterionic PC-
containing polymers by either blending or surface grafting have
previously been shown to have reduced thrombogenicity both
in vitro and in vivo.25−27 However, these approaches are limited
by the amount of PC-containing polymer that might be
blended and still preserve mechanical properties, the elution of
PC-containing blended polymer as the primary polymer
component degrades, and concerns of underlying substrate
exposure at later times with loss of surface bound moieties from
polymers with zwitterion surface-grafting. Thus, in this study, a
hydrolytically labile polyurethane with variable SB content as
part of the polymer backbone was designed that would
putatively be a fully degradable nonthrombogenic elastomer
with physical and nonthrombogenic properties being tunable
with the SB composition.
Cao et al.17 have reported the synthesis of an SB-containing
polycaprolactone (PCL-APS) by mixing a similar SB-diol and
an ε-caprolactone (CL) monomer to initiate ring-opening
polymerization. The molecular weight of PCL-APS was
changed by varying the ratio of monomer (CL) to the initiator
(SB-diol) to alter the number of repeating CL units. Further,
they also synthesized a polyurethane with SB by chain
extension of the PCL-APS with hexamethylene diisocyanate.18
However, this approach varies from the current report in that
control of SB content in the polyurethane was ﬁxed at one SB
per diol, whereas here the ratio of PCL-diol and SB diol could
be varied to tune the physical properties of the PESBUUs in
addition to the degradation and thrombogenic behavior.
Further, with the current synthetic approach, the SB portion
could be regarded as part of the hard-segment in the PESBUUs.
With increased SB content, PCL soft segment content
decreased and thus the portion of hard segments was increased.
The initial modulus of PESBUU-75 in the dry state (90 MPa)
was signiﬁcantly increased versus PESBUUs with lower SB
content, and the PESBUU-100 synthesized from only SB-diol
was more stiﬀ (265 MPa initial modulus), with the lowest
breaking strain. This eﬀect could be attributed to the greater
hard segment content for these PESBUUs with limited PCL
soft segment content. However, both the initial modulus and
tensile strength of PESBUU-75 were dramatically decreased
(16 and 15 MPa, respectively) in wet conditions. The large
changes in wet conditions compared with lower SB content
polymers (PESBUU-25 and PESBUU-50) might be related to
the increased swelling of the high SB-content PESBUUs and
chain rearrangement related to the zwitterionic components.18
Degradation of the synthesized polymers in DPBS solution
alone was markedly slower and did not vary notably among the
polymer types compared to when lipase was present. PESBUU
Figure 10. (A) Electrospun conduits of PESBUU-50 with diﬀerent diameters (1.0 mm, left; and 1.6 mm, right) (B) macroscopic and (C) scanning
electron micrographs of electrospun PESBUU sheets after contact with ovine blood (heparin 3U/mL) for 3 h at 37 °C.
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degradation is presumably due to ester bond cleavage of the
soft segment PCL, relatively slowly degrading polyester due to
its hydrophobicity and crystallinity. Hydrogen bonding in the
polyurethane may also reduce the hydrolytic degradation rate of
the PCL soft segments. Enzymatic degradation of PESBUUs in
lipase obviously accelerated polymer degradation, suggesting
that the polyurethanes would degrade faster in vivo than in
vitro, as has been previously observed with similar polyur-
ethanes.31,32 On the other hand, the diﬀerence in the polymer
degradation proﬁles in lipase (Figure 7) was pronounced, with
SB moiety introduction signiﬁcantly reducing degradation. An
increase in the SB portion (PCL portion decrease) led to
slower degradation such that the mass loss of PESBUU-75 was
less than 10% during the 3 month in a lipase solution. The
decreased enzymatic degradation with increased SB might be a
result of increased hard segment content,31,33 and the
concomitant decrease in hydrolytically labile polyester with
the decrease in the soft segment. One further consideration is
that as the zwitterion content increases, resistance to protein,
and thus enzyme, interactions on the PESBUU polymer
surfaces might reduce the ability of these proteins to catalzye
the degradation reaction.34 Additionally, the crystallinity of
PCL blocks together with changes in the SB portions (hard-
segments) of PESBUUs might also be important to explain the
polymer degradation and the mechanical properties of the
electrospun conduits and ﬁlms. Further detailed studies might
be pursued to deﬁne the relationship of the polymer
degradation and mechanical properties with the polymer
crystallinity using multiple methods (e.g., X-ray scattering and
DSC).
Several previous studies have shown reduced protein
adsorption in the presence of zwitterionic moieties, and the
association of this low protein adsorption with decreased
platelet deposition.11−13,18,24,30 PESBUU polymers containing
SB moieties had lower ﬁbrinogen adsorption on the surfaces
compared to the control, and the amount of adsorbed
ﬁbrinogen decreased with increasing the SB content. Platelet
deposition was markedly decreased in general correspondence
with the SB content of the polymers. While it has been shown
that the activity of ﬁbrinogen on the surface in terms of platelet
binding can be independent of the total amount of ﬁbrinogen
adsorbed,35 the data of this report suggest that reductions in
protein adsorption might be responsible for the reduced
platelet deposition. Further, it was shown that these
biodegradable SB-bearing polyurethanes maintained their
nonthrombogenic properties after periods of degradation,
which might not be expected with surface modiﬁcation or
grafting approaches on degradable polymers. This sustained
thromboresistance is a relevant property for applications where
late thrombosis36,37 might be a concern.
In addition to the characterization of PESBUU polymer
ﬁlms, ﬁbrous sheets, and small diameter conduits were
fabricated by electrospinning. These processed surfaces
exhibited signiﬁcantly reduced thrombotic deposition with
increasing SB content (Figure 10B, C) and suggested the
feasibility of applying this material in the creation of a tissue
engineered small diameter vascular graft (Figure 10A). As
expected from the study of the polymer ﬁlms, the PESBUU-50
electrospun sheet also was resistant to platelet deposition, and
had mechanical properties similar to PESBUU-0 under wet
conditions and at 37 °C, that has previously been evaluated as a
vascular replacement graft in rodents.25,26 PESBUU-0 exhibited
values of both initial elastic moduli and global compliance
comparable to those reported in previously,25 and the
compliance of PESBUU 50 and PESBUU 75 showed global
compliance values in a range similar to native blood vessels (4−
5 × 10−4 mm Hg−1).38 Further studies might be directed to
optimize the electrospinning process for vascular graft
fabrication depending on speciﬁc PESBUU polymer character-
istics. As can be seen in the diﬀerent intrinsic viscosities of the
diﬀerent PESBUU polymer solutions (Table 1), variable
incorporation of the zwitterionic SB moieties in polymer
altered the solution behavior and thus would impact the
processing parameters to achieve eletrospun scaﬀolds with
desired morphological characteristics such as ﬁber diameter,
ﬁber density, and porosity.
This report is limited in several aspects, particularly with
respect to the appropriateness of the materials for the
speculated cardiovascular applications. The assessment of
nonthrombogenic behavior has been done with an acute, in
vitro, ovine blood contacting test with anticoagulants present.
Although this test provided relative discrimination between
polymer types, the lack of thrombotic deposition here might
not translate to various clinical applications directly. Also along
these lines, the in vitro degradation, even with enzymes, does
not capture the complex in vivo situation where phagocytic
leukocyte involvement results in an array of enzymes and other
factors (e.g., strong oxidants) that would generally be expected
to accelerate degradation and the loss of mechanical properties.
This report did not investigate the loss of mechanical properties
with degradation, and this is a relevant feature for load-bearing
scaﬀolds placed in many applications. For instance, early loss of
mechanical properties might lead to aneurysmal dilatation of a
vascular scaﬀold if not enough tissue ingrowth has occurred to
compensate. In that this report describes the method for the
generation of a family of degradable nonthrombogenic
polyurethanes, the means to tune the selection of an
appropriate polymer where trade oﬀs are made between
various physical and functional considerations is present.
Furthermore, polymers similar to PESBUU-0 have been
implanted in functional locations in small animal models and
shown polymer degradation accompanied by tissue remodeling
appropriate to maintain mechanical viability or mechanical
eﬀect.39−41
On the basis of the limited assessments of this manuscript,
the PESBUU-50 appears to provide the most attractive
compromise between high strength (over 30 MPa) and strain
(over 700%) under both dry and wet conditions, processability
and thromboresistance, although PESBUU-75 had somewhat
similar behavior. Those polymers could be fabricated into
electrospun conduits that qualitatively appeared mechanically
appropriate for vascular scaﬀold applications.42−45 Further-
more, the fully degradable PESBUU elastomers might also ﬁnd
other suitable cardiovascular applications including coatings for
a drug-eluting biodegradable stent46 as well as tissue engineered
heart valves.47,48
■ CONCLUSIONS
A series of biodegradable and robust elastic polyurethanes were
synthesized with SBs as part of the polymer backbone
(PESBUUs), and where the SB content in the polymer could
be easily tuned by altering the molar ratio of PCL and SB diol
reactants. The mechanical and degradation properties were
sensitive to the SB content, with enzymatic degradation being
dependent on the PCL content. At higher zwitterionic molar
ratios (PESBUU-50 and PESBUU-75) markedly reduced
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thrombotic deposition was observed both before and after
substantial degradation. The mechanical and degradation
properties as well as the acute in vitro thrombogenicity
assessment suggest that these polymers would be appropriate
for use in blood contacting applications where a degradable,
elastomeric component with enduring thromboresistance is
desired.
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